This inventor holds 1 USPTO granted patent. Top assignee: Dsm IP Assets B.v.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Joannes Gerardus Kierkels: Innovator in Sugar Chemistry
Introduction
Joannes Gerardus Kierkels is a notable inventor based in Sittard, Netherlands. He has made significant contributions to the field of sugar chemistry, particularly in the preparation of specific hexoses. His innovative work has led to the development of a patented process that holds promise for medicinal applications.
Latest Patents
Kierkels holds a patent for a process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses. This invention involves a method that utilizes a substituted or unsubstituted carbonyl compound with at least two carbon atoms and at least one α-hydrogen atom, along with a substituted or unsubstituted aldehyde. The process is carried out in the presence of an aldolase and water, ensuring that the carbonyl concentration does not exceed six moles per liter of the reaction mixture. The final concentration of the resulting hexoses is at least two mass percent of the reaction mixture. This innovative process has potential applications in the preparation of medicines, particularly statins.
Career Highlights
Kierkels is associated with Dsm IP Assets B.V., where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but has also paved the way for new medicinal formulations.
Collaborations
Throughout his career, Kierkels has collaborated with esteemed colleagues such as Sven Panke and Franciscus Alphons Lommen. These partnerships have enhanced the scope and impact of his research.
Conclusion
Joannes Gerardus Kierkels is a distinguished inventor whose work in sugar chemistry has led to valuable innovations. His patented process for preparing specific hexoses demonstrates his commitment to advancing medicinal chemistry. His contributions continue to influence the field and hold promise for future developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
